Antimicrobial activity of gatifloxacin compared to seven other compounds tested against Gram-positive organisms isolated at 10 cancer-treatment centers-Reference-Cited by-同舟云学术

Antimicrobial activity of gatifloxacin compared to seven other compounds tested against Gram-positive organisms isolated at 10 cancer-treatment centers

Published:1999-05 Issue:1 Volume:34 Page:37-43
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Diekema Daniel J,Jones Ronald N,Rolston Kenneth V.I

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference21 articles.

1. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin, and ciprofloxacin;Bauenfiend;J Antimicrob Chemother,1997

2. Bacteremia due to viridans streptococci in neutropenic patients;Bochud;Am J Med,1994

3. Comparison of ciprofloxacin, ofloxacin, and pefloxacin for the prevention of the bacterial infection in neutropenic patients with a hematological malignancies;D’Antonio;J Antimicrob Chemother,1994

4. Septicemia and shock syndrome due to viridans streptococci;Elting;Clin Infect Dis,1992

5. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility;Hiramatsu;J Antimicrob Chemother,1997

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stability indicating HPLC method for the simultaneous analysis of Gatifloxacin and Loteprednol in eyedrop formulation using design of experiment approach;Indian Journal of Chemical Technology;2023

2. Bacterial and Atypical Infections in Critically Ill Cancer Patients;Oncologic Critical Care;2019-10-13

3. Bacterial and Atypical Infections in Critically Ill Cancer Patients;Oncologic Critical Care;2019

4. Activity In Vitro of the Quinolones;Quinolone Antimicrobial Agents;2014-04-08

5. Neutropenic Fever and Sepsis: Evaluation and Management;Infectious Complications in Cancer Patients;2014